leisure time -WSS

leisure time

author：leisure time 2025-10-02 18:48:13 - browse：389

Truvian Health employee with a plate holding reagents used to measure commonly tested blood markers. Truvian

SAN DIEGO — Truvian Health, a San Diego blood diagnostics company, shared data on Tuesday showing that its benchtop instrument’s results are largely consistent with those generated by large central laboratories. But while the results lend support for the company’s vision of decentralized and widely available clinical testing, they also resurface questions about the value of an approach widely associated with the now defunct and notorious Bay Area startup Theranos.

In a multisite study, the company tested nearly 240 blood samples from healthy donors and chronic disease patients for dozens of blood-based measurements commonly ordered by doctors, from cholesterol to blood sugar to blood cell counts. Results from Truvian’s benchtop analytical instrument, with few exceptions, closely matched readings from devices used in large central labs and made by Swiss pharma giant Roche and Japanese firm Sysmex.

The findings were presented at the annual meeting of the American Association for Clinical Chemistry, recently rebranded as the Association for Diagnostics & Laboratory Medicine. It’s the first time Truvian has shared clinical data on its product, though they have not been published in a peer-reviewed journal. The company, which is planning additional validation studies, expects to submit for Food and Drug Administration approval of its device by the third quarter of 2024.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Heart disease and mental health: A look at cardiac psychology

leisure time

WSS

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Biden warns of ‘dark winter’ during final presidental debate

How doctors’ personal politics affect patients

Democrats decry new health bill for going easy on private equity

The nurse manager staffing crisis is hurting patients

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

knowledge

leisure time

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

Three issues to watch in global health in 2024

Hollywood unions extend contract negotiations for actors

In the gardens at Boston Children's Hospital, families find sanctuary

United colonoscopy coverage change 'may cost lives,' doctors say

A new crop of companies is reshaping the health data economy

New air purifier tech could be key to improving indoor air quality

As JPM 2024 winds down, some health tech firms project optimism

Virginia high school admissions case could be legal follow

UHS says company favors patients whose insurance pays more

hotspot

STAT Report: Patient voices and perspectives

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

In the gardens at Boston Children's Hospital, families find sanctuary

Democrats decry new health bill for going easy on private equity

Risky weight loss products often used by teens globally, per study

Generative AI mines health records to identify patients’ social needs

focus

leisure time

leisure time

Wikipedia